MRI-guided stereotactic ablative radiation therapy for liver metastasis from pancreatic cancer.

J Cancer Res Ther

Department of Radiation Oncology, Tokyo-Edogawa Cancer Centre, Edogawa Hospital, Tokyo, Japan.

Published: December 2022

A 69-year-old man with a history of pancreatic cancer was referred to our hospital for a newly developed solitary liver metastasis. Since the liver metastasis was in contact with the small intestine, it was necessary to perform radiation therapy while simultaneously monitoring the small intestine and liver metastasis, and then, MRI-guided stereotactic ablative radiation therapy (SABR) was performed. There were no radiation-induced adverse events during the treatment and 6 months of follow-up. MRI showed complete regression of the tumor at 6 months after SABR. It seems feasible to perform SABR safely by using MRI-guided radiation therapy system even if liver metastasis developed near the intestinal tract after surgery for pancreatic cancer.

Download full-text PDF

Source
http://dx.doi.org/10.4103/jcrt.JCRT_1091_20DOI Listing

Publication Analysis

Top Keywords

liver metastasis
20
radiation therapy
16
pancreatic cancer
12
mri-guided stereotactic
8
stereotactic ablative
8
ablative radiation
8
small intestine
8
liver
5
metastasis
5
radiation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!